Login or Sign Up
15:58 Feb 26
Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Divi's Laboratories Ltd. News And Announcements
Divi's Laboratories Ltd.
Industry Pharmaceuticals
15:58 Feb 26
Quality
75/100
High Financial Strength
Valuation
24/100
Expensive Valuation
Technical
53/100
Technically Neutral
Strength
6
Weakness
3
Opportunity
1
Threats
1
1.72L
Market Cap (Cr)
69.33
PE Ratio
11.02
Price to Book Ratio
RSI
23.40 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully